Fund Holdings — GILEAD SCIENCES, INC.

Total Portfolio Value:
$1.46B
Total Bought:
$0
Total Sold:
$0
Net Transaction:
$0
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Arcus Biosciences, Inc.(RCUS)31,424,76031,424,7600$968.83M$811.70M55.45%-$157.12M
Lakefront Biotherapeutics NVADR(LKFT)16,707,47716,707,4770$500.16M$501.28M34.24%+$1.13M
Assembly Biosciences Inc.4,977,0894,977,0890$136.77M$116.91M7.99%-$19.86M
Kyverna Therapeutics Inc.4,126,1194,126,1190$36.76M$28.06M1.92%-$8.71M
Xilio Therapeutics Inc.650,389650,3890$6.23M$5.89M0.40%-$344.7K
Page 1 of 1
GILEAD SCIENCES, INC. — 13F Holdings — Q3 2026 | TickerTrail